Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.jconrel.2005.08.013
Title: Paclitaxel-loaded PLGA nanoparticles: Potentiation of anticancer activity by surface conjugation with wheat germ agglutinin
Authors: Mo, Y.
Lim, L.-Y. 
Keywords: A549
Anticancer activity
CCL-186
H1299
Isopropyl myristate (IPM)
Lung cancer
Paclitaxel
PLGA nanoparticle
Wheat germ agglutinin (WGA)
Issue Date: 28-Nov-2005
Citation: Mo, Y., Lim, L.-Y. (2005-11-28). Paclitaxel-loaded PLGA nanoparticles: Potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. Journal of Controlled Release 108 (2-3) : 244-262. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jconrel.2005.08.013
Abstract: Purpose: To potentiate the anticancer activity of paclitaxel-loaded PLGA nanoparticles through surface conjugation with wheat germ agglutinin (WGA). Methods: PLGA nanoparticles loaded with paclitaxel and isopropyl myristate (IPM) as release modifier were prepared by a solvent evaporation method. WGA was conjugated to the nanoparticle surface to give novel WIT-NP of 330 ± 3 nm. In vitro cytotoxicity of WIT-NP against malignant (A549 and H1299) and normal (CCL-186) pulmonary cell lines was evaluated alongside control formulations. IC50 doses were determined by the MTT assay, while cellular apoptosis was detected by cell nuclei staining and DeadEnd™ Fluorometric TUNEL assay. Cell cycle arrest was confirmed by flow cytometry. Cellular uptake of 3[H]-paclitaxel from the test and control formulations was also quantified. In vivo anticancer efficacy was evaluated in the SCID mice model engrafted with the A549 tumor nodule. Results: WIT-NP had superior anti-proliferation activity against the A549 and H1299 cell lines compared with conventional paclitaxel formulations as measured by IC50 doses. This was attributed to a more efficient intracellular accumulation of paclitaxel via WGA-receptor-mediated endocytosis and IPM-facilitated intracellular paclitaxel release. WIT-NP activity was associated with paclitaxel-induced apoptosis and cell arrest in the G2/M phase. A single intratumoral injection of WIT-NP at paclitaxel dose of 10 mg/kg inhibited the growth of A549 tumor nodules without inducing significant weight loss in the SCID mice over a period of 25 days. Tumor doubling time was greater than 25 days, compared with 11 days for nodules treated with conventional paclitaxel formulation. Conclusion: The formulation of WIT-NP, in which WGA is conjugated to the surface of paclitaxel and IPM-loaded PLGA nanoparticles, significantly potentiates the anticancer activity of paclitaxel.
Source Title: Journal of Controlled Release
URI: http://scholarbank.nus.edu.sg/handle/10635/106194
ISSN: 01683659
DOI: 10.1016/j.jconrel.2005.08.013
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

104
checked on Aug 22, 2019

WEB OF SCIENCETM
Citations

94
checked on Aug 22, 2019

Page view(s)

38
checked on Aug 16, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.